Compounds > ascorbic-acid

ascorbic-acid and Tuberculosis--Multidrug-Resistant

ascorbic-acid has been researched along with Tuberculosis--Multidrug-Resistant* in 2 studies

Reviews

1 review(s) available for ascorbic-acid and Tuberculosis--Multidrug-Resistant

ArticleYear
A pro-oxidant property of vitamin C to overcome the burden of latent
    Frontiers in cellular and infection microbiology, 2023, Volume: 13

    Tuberculosis (TB), caused by the bacillus

    Topics: Antitubercular Agents; Ascorbic Acid; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Reactive Oxygen Species; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Vitamins

2023

Other Studies

1 other study(ies) available for ascorbic-acid and Tuberculosis--Multidrug-Resistant

ArticleYear
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:3

    The treatment of drug-susceptible tuberculosis (TB) is long and cumbersome. Mismanagement of TB treatment can lead to the emergence of drug resistance in patients, so shortening the treatment duration could significantly improve TB chemotherapy and prevent the development of drug resistance. We previously discovered that high concentrations of vitamin C sterilize cultures of drug-susceptible and drug-resistant

    Topics: Animals; Antitubercular Agents; Ascorbic Acid; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Isoniazid; Lung; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant

2018